西藏藏药集团股份有限公司

What 西藏藏药集团股份有限公司 does

西藏藏药集团股份有限公司 (Tibet Tibetan Medicine Group Co., Ltd.) is a private joint-stock pharmaceutical manufacturer established in 1994 as one of 62 national aid-Tibet key projects, with investment from the Jiangsu Provincial Government. It is Tibet's first modern Tibetan medicine enterprise and the first GMP-certified Tibetan medicine company in the region, headquartered at Lhasa with a packaging factory in Chengdu (Wenjiang District). The company develops, manufactures, and distributes a portfolio of 10 core pharmaceutical products based on classical Tibetan medical texts including the Four Tantras (四部医典), spanning capsules, granules, and oral liquids for respiratory conditions (Shiwei Longdanhua series), digestive and lipid disorders (Liuwei Nengxiao), altitude sickness (Hongjingtian Oral Liquid), pain management (Duyiwei Granules), cardiovascular health (Ningxinbao Capsules), and liver/immune support (Liganlong Granules, Bawei Zhangyacai Capsules). Several products hold national-level regulatory protection including national secrecy formula, geographical indication, and traditional Chinese medicine protection statuses. The company also markets premium herbal materials (cordyceps, saffron, snow chrysanthemum, rhodiola) and consumer health products (highland barley flakes, Tibetan tea).

The company's business model rests on a sales-led, hospital-centric go-to-market motion: it sells prescription products through national and provincial drug tendering processes to hospitals and Tibetan medicine hospitals across China, supported by a dedicated marketing center with regional sales representatives conducting academic promotion (学术推广) and clinical exchange meetings. Distribution combines direct sales to healthcare institutions with retail pharmacy channels for OTC products. Revenue is generated from three streams: pharmaceutical product sales (prescription and OTC), premium herbal material sales, and consumer health products. Multiple wholly-owned subsidiaries support operations, including Jiuzhaigou Shengya Tibetan Medicine (cultivation base) and Tibet Tibetan Medicine (Group) Lizhongyuan Biotechnology (distribution). The company holds a strategic partnership with Qizheng Tibetan Medicine (奇正藏药), the controlling shareholder group, which provides capital injection and integration into a broader multi-product marketing strategy. The firm maintains proprietary cultivation bases (150 acres plus 5 greenhouses) in Tibet and Sichuan for endangered Tibetan medicinal herbs, and is investing in a new modern production base at the Lhasa Economic Development Zone announced in 2025.

Name

西藏藏药集团股份有限公司

Legal name

西藏藏药集团股份有限公司

Website

https://xzzy.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

西藏藏药集团股份有限公司 manufactures and distributes traditional Tibetan medicine pharmaceuticals, operating Tibet's first GMP-certified modern Tibetan medicine enterprise with 10 core products sold through hospital procurement and pharmacy channels across China, plus premium herbal materials and consumer health products.

Ownership category

akta.pro rank

Product category

Traditional Tibetan Medicine Pharmaceuticals

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Herbal & Botanical Supplements (CRADAGAD)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Tea (Leaf, Bagged, Instant, Concentrates) (CRADAHAE)

Keywords

• Tibetan pharmaceutical products
• Traditional Tibetan medicine
• GMP-certified pharmaceutical manufacturing
• Tibetan herbal medicine capsules
• Chinese ethnic medicine production

Headquarters

HQ city

Lhasa

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from the production and sale of Tibetan medicine pharmaceutical products including capsules, granules, and oral liquids. Products are distributed through hospital procurement, pharmacies, and medical institutions.
2. Premium Herbal Materials Sales: Sale of high-value Tibetan herbal materials including cordyceps, saffron, snow chrysanthemum, and rhodiola.
3. Healthy Consumer Products: Revenue from functional foods and health products including highland barley flakes and Tibetan tea marketed through the company's distribution network.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

西藏藏药集团股份有限公司 manufactures and sells traditional Tibetan medicine pharmaceutical products in modern dosage forms (capsules, granules, oral liquids) under GMP-certified facilities, with a portfolio of approximately 10 core prescription medicines for respiratory, digestive, cardiovascular, hepatic, and altitude-related conditions, plus premium Tibetan herbal ingredients (cordyceps, saffron, snow chrysanthemum, rhodiola) and functional foods (highland barley flakes, Tibetan tea). Products are distributed primarily through hospital procurement and pharmacy channels across China, with company-owned cultivation bases supplying endangered Tibetan Plateau medicinal herbs.

Product overview

西藏藏药集团股份有限公司 is a Tibetan pharmaceutical company offering a comprehensive portfolio of traditional Tibetan medicine products and health supplements. The main product line includes 10 core pharmaceutical products such as 十味龙胆花颗粒/胶囊 (for respiratory conditions), 六味能消胶囊 (for digestive and lipid conditions), 红景天口服液 (anti-high altitude reaction), 独一味颗粒 (pain relief), and others for liver, cardiovascular, and general wellness applications. The贵细药材 (premium herbal ingredients) category features，冬虫夏草, 藏红花, 雪菊, and 红景天. The大健康产品 (big health) line includes functional foods like 青稞麦片 and 藏茶. The company operates as a modern pharmaceutical manufacturer with GMP-certified production facilities and a subsidiary focused on traditional Tibetan medicine distribution.

Differentiator

Problem solved

Functional benefit

Products and services

• 十味龙胆花颗粒 (Shiwei Longdanhua Granules) Tibetan medicine preparation for clearing heat, resolving phlegm, relieving cough and asthma. Used for cough, asthma, and phlegm-yellow symptoms caused by phlegm-heat obstructing the lung, as well as acute exacerbations of bronchitis. National secrecy formula variety.
• 十味龙胆花胶囊 (Shiwei Longdanhua Capsule) Tibetan medicine formulation composed of 10 natural Tibetan herbal ingredients for clearing heat, resolving phlegm, relieving cough and asthma. Used for cough, asthma, phlegm-yellow symptoms, and acute/chronic bronchitis. National exclusive variety and national geographical indication protection product.
• 六味能消胶囊 (Liuwei Nengxiao Capsule) Tibetan medicine for wide middle regulation, laxative effect, and blood lipid regulation. Used for gastric distension and pain, anorexia, indigestion, constipation, hyperlipidemia, and obesity. National traditional Chinese medicine protection variety recommended by the China Ethnic Minority Medical Association.
• 红景天口服液 (Hongjingtian Oral Liquid) Tibetan medicine to invigorate qi and promote blood circulation. Used for high-altitude reaction and physical weakness. The only Rhodiola oral solution with national drug approval number and the only Rhodiola product included in the 2005 Chinese Pharmacopoeia for anti-altitude sickness indication.
• 独一味颗粒 (Duyiwei Granules) Tibetan medicine for activating blood circulation, stopping pain, removing stasis and stopping bleeding. Used for post-surgical wound pain and bleeding, fractures, soft tissue injuries, rheumatic arthralgia, and menorrhagia/dysmenorrhea.
• 宁心宝胶囊 (Ningxinbao Capsules) Tibetan medicine made from fresh Cordyceps sinensis isolated fungi. Improves premature beats, sinoatrial block, and atrioventricular conduction function, and improves cardiac function. Used for various arrhythmias, atrioventricular block, and refractory slow-type arrhythmias.
• 脂必妥胶囊 (Zhibituo Capsules) Tibetan medicine for strengthening spleen, removing dampness and phlegm, promoting blood circulation and removing blood stasis. Used for spleen dampness obstruction, shortness of breath, dizziness and headache, hyperlipidemia, and auxiliary treatment of atherosclerotic conditions.
• 八味獐牙菜胶囊 (Bawei Zhangyacai Capsules) Tibetan medicine for clearing heat and anti-inflammatory purposes. Used for cholecystitis and early-stage icteric hepatitis B. National exclusive variety.
• 利肝隆颗粒 (Liganlong Granules) Tibetan medicine for soothing liver and relieving depression, clearing heat and detoxification. Used for acute and chronic active hepatitis, with significant reduction effects on ALT, jaundice index, and musk草浊度.
• 杞菊地黄胶囊 (Qiju Dihuang Capsules) Tibetan medicine for nourishing kidney and liver. Used for liver-kidney yin deficiency symptoms including dizziness, tinnitus, photophobia, and blurred vision.
• 冬虫夏草 (Premium Cordyceps / 贵细药材) Premium Tibetan herbal ingredient marketed to regulate the immune system, directly inhibit tumors, delay aging, protect liver and kidney, and resist fatigue and radiation.
• 藏红花 (Premium Tibetan Saffron / 贵细药材) Premium Tibetan herbal ingredient for enhancing immunity, radiation protection, appetite stimulation, sleep promotion, health maintenance, and anti-aging.
• 雪菊 (Snow Chrysanthemum / 贵细药材) Premium Tibetan herbal ingredient for high-efficiency blood lipid reduction, blood vessel softening, lipid dissolution, weight loss, detoxification and beauty, sleep quality improvement, and heart muscle nourishment.
• 红景天 (Premium Rhodiola / 贵细药材) Premium Tibetan herbal ingredient for anti-high-altitude hypoxia, improving brain and heart oxygen supply, radiation resistance, vitality improvement, anti-fatigue, immunity enhancement, and learning and memory improvement.
• 青稞麦片 (Highland Barley Flakes) Functional food made from natural pollution-free highland barley grown at 3,500-meter altitude, with no chemical additives. Particularly suitable for diabetes patients, three-high populations (hypertension/hyperglycemia/hyperlipidemia), weight loss and beauty consumers, and those seeking green unpolluted lifestyle.
• 藏茶 (Tibetan Tea) Black tea category fully fermented tea made from mature tea leaves and red buds harvested from highlands above 1,000 meters in Hainan through a special process. A primary daily beverage of Tibetan compatriots with over 1,300 years of history.

Quantifiable outcome

• 150 acres outdoor standardized planting base plus 5 greenhouse seedling bases established for endangered Tibetan medicinal herbs
• +1 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Six partnerships are on record, tiered minor and core.

• 澳门大学中华医药研究院 / 中药质量研究国家重点实验室minorStrategic or Co-development Partner · 20 October 2017Visit and exchange in October 2017. Discussed 'Tibet-Macao cooperation', 'technology-based targeted poverty alleviation', and 'five-in-one' cooperation concepts. Explored potential collaboration in ethnic medicine (Tibetan medicine) development, quality control, technology, talent cultivation, and enterprise technological innovation.
• 九寨沟县人民政府coreStrategic or Co-development Partner · 16 February 2017Strategic cooperation agreement signed on February 16, 2017 for Tibetan (Chinese) herb industrialization development project in Jiuzhaigou County. Adopted the 'enterprise + research institute + demonstration base + professional cooperative + farmer household' development model. The subsidiary 圣雅藏药 registered with 10 million RMB capital to implement the project.
• 成都中医药大学民族医药学院coreStrategic or Co-development Partner · 26 May 2016Long-term internship base partnership with renewal signing ceremony in 2016. Joint talent cultivation, academic lectures, job training, and collaborative research project applications. The partnership includes joint establishment of 'Tibetan Medicine Group Teaching Practice Base' at the university. General Manager Zhang Ming was appointed as a visiting professor at the university in 2016.
• 西藏大学医学院minorStrategic or Co-development Partner · 22 October 2013Cooperation agreement signed covering Tibetan herb artificial seedling cultivation and demonstration planting. Joint research on Tibetan herb product development and cultivation technology.
• 九寨沟县圣雅藏药有限公司coreStrategic or Co-development PartnerWholly-owned subsidiary of Tibet Tibetan Medicine Group registered in Jiuzhaigou County in April 2017 with 10 million RMB capital. Focuses on mid-altitude Tibetan/Chinese herb cultivation research base, precision poverty alleviation, and industrial development. The subsidiary actively participates in disaster relief, public welfare, and local community engagement in Jiuzhaigou.
• 中国民族医药学会coreStrategic or Co-development PartnerCompany participated in the association's annual meetings and academic conferences. Chairman Luo Wenbin was elected as a standing director, General Manager Zhang Ming as Vice President, and R&D Director Qiu Xiaojun and Marketing Director Zhao Jiumin as directors at the Health Care and Wellness Branch.

Scale indicators4 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Tongrentang (同仁堂): Tongrentang (600085.SH) is China's most iconic traditional Chinese medicine company with national distribution, established consumer brand, and product overlap in respiratory and cardiovascular indications. Operates at much larger scale and competes for hospital tender and pharmacy shelf space across the same therapeutic categories.
• Yunnan Baiyao Group (云南白药): Yunnan Baiyao (000538.SZ) is a major traditional Chinese medicine and consumer health products company with broad product portfolio including herbal-based pharmaceutical preparations. Established national brand and significantly larger distribution network creates competitive pressure in pharmacy and consumer health channels.
• Pien Tze Huang (片仔癀): Pien Tze Huang (600436.SH) is a premium traditional Chinese medicine brand with national hospital and retail presence. Competes in the broader TCM pharmaceutical preparation category with similarly regulated proprietary formulations and strong brand pricing power.
• Taiji Group (太极集团): Taiji Group (600129.SH) is a major Sichuan-based TCM manufacturer with overlapping product categories in respiratory (Huo Xiang Zheng Qi) and cardiovascular therapeutic areas. Comparable in geographic base (Sichuan) and broader hospital channel coverage.
• Guilin Sanjin (桂林三金):

Direct peers

• Jinhe Tibetan Medicine (金诃藏药): Jinhe Tibetan Medicine is a Qinghai-based Tibetan medicine manufacturer with similar product positioning across Tibetan botanical pharmaceutical preparations. Comparable in terms of GMP-certified manufacturing, hospital channel distribution, and dependence on Qinghai-Tibet plateau raw materials.
• Tibet Pharmaceuticals (西藏药业): Tibet Pharmaceuticals (600211.SH) is a Tibet-based publicly-listed pharmaceutical company with overlap in Tibetan plateau-sourced medicine manufacturing, although broader in scope (including biotechnology and cardiovascular products). Comparable in regional production base and regulatory positioning.
• Qizheng Tibetan Medicine (奇正藏药): Qizheng Tibetan Medicine (002287.SZ) is the controlling shareholder group of Tibet Tibetan Medicine Group and the largest publicly-listed Tibetan medicine company in China. Both companies share Tibetan medicine formulation science, GMP-certified manufacturing, and overlap in product categories (pain relief, anti-inflammatory, altitude sickness). Qizheng provides capital, strategic oversight, and distribution integration for this subsidiary.
• Jingzhu Tibetan Medicine (晶珠藏药): Jingzhu Tibetan Medicine is another Tibetan medicine manufacturer operating in similar therapeutic areas including respiratory, digestive, and cardiovascular formulations. Direct overlap in product categories and distribution channels.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E8%A5%BF%E8%97%8F%E8%97%8F%E8%8D%AF%E9%9B%86%E5%9B%A2%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 西藏藏药集团股份有限公司